BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15956426)

  • 1. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay.
    Vignoli R; Varela G; Mota MI; Cordeiro NF; Power P; Ingold E; Gadea P; Sirok A; Schelotto F; Ayala JA; Gutkind G
    J Clin Microbiol; 2005 Jun; 43(6):2940-3. PubMed ID: 15956426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.
    Franiczek R; Sobieszczańska B; Turniak M; Kasprzykowska U; Krzyzanowska B; Jermakow K; Mokracka-Latajka G
    Adv Clin Exp Med; 2012; 21(2):187-92. PubMed ID: 23214282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.
    Brigante G; Luzzaro F; Perilli M; Lombardi G; Colì A; Rossolini GM; Amicosante G; Toniolo A
    Int J Antimicrob Agents; 2005 Feb; 25(2):157-62. PubMed ID: 15664486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
    Subramaniam G; Palasubramaniam S; Navaratnam P
    Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of antibiotic resistance in enteropathogenic Escherichia coli carrying extended-spectrum beta-lactamases recovered from diarrhoeic rabbits.
    Poeta P; Radhouani H; Gonçalves A; Figueiredo N; Carvalho C; Rodrigues J; Igrejas G
    Zoonoses Public Health; 2010 May; 57(3):162-70. PubMed ID: 19309480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
    Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
    J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility to antimicrobial agents of enteroaggregative Escherichia coli strains isolated from children with diarrhea].
    Sobieszczańska B; Kowalska-Krochmal B; Mowszet K; Pytrus T
    Przegl Epidemiol; 2003; 57(3):499-503. PubMed ID: 14682169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America.
    Pallecchi L; Bartoloni A; Fiorelli C; Mantella A; Di Maggio T; Gamboa H; Gotuzzo E; Kronvall G; Paradisi F; Rossolini GM
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2720-5. PubMed ID: 17548490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.
    Pitout JD; Hanson ND; Church DL; Laupland KB
    Clin Infect Dis; 2004 Jun; 38(12):1736-41. PubMed ID: 15227620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.